Arabin Pessary in Singleton Pregnancy

National University of Malaysia58 enrolled

Overview

This was a retrospective study sharing the experience of women high risk for spontaneous preterm birth managed by Arabin pessary.

The study recruitment was from 1st January 2013 until 31st December 2019. Inclusion criteria were previous mid-trimester miscarriage and/or preterm birth, previous cervical surgery or short cervical length on routine ultrasound. The primary outcome measure was birth before 34 weeks gestation.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Previous Mid Trimester Miscarriage Previous Preterm Birth Previous Cervical Surgery Short Cervix on Ultrasound

Interventions

Arabin pessaryDEVICE

Arabin pessary was inserted intravaginally electively in women with cervical insufficiency (history based) or as emergency in those with short cervix on ultrasound.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all women high risk for spontaneous preterm birth Exclusion Criteria: * had Arabin insertion elsewhere * delivered elsewhere * incomplete record

Locations (1)

National University of Malaysia

Cheras, Kuala Lumpur, Malaysia

Outcomes

Primary Outcomes

Birth at or more than 34 weeks

Gestation of birth in percentage that occurred at or more than 34 weeks gestation

Time frame: From insertion of the Arabin pessary until birth of the foetus

Secondary Outcomes

Type of labour

Type of labour whether spontaneous or induced

Time frame: From insertion of the Arabin pessary until birth of the foetus

Mode of delivery

Mode of delivery whether vaginal or caesarean section

Time frame: From onset of labour until birth of the foetus

Median birth weight

Median neonatal birth weight in gram

Time frame: At birth

Admission into neonatal intensive care unit

The need to admit the neonate to neonatal care intensive care unit at birth

Time frame: At birth until discharged from the hospital

Mean cervical length

The mean cervical length at insertion of the Arabin pessary

Time frame: At insertion of the Arabin pessary

Subsequent management

The management of the patients after insertion of the Arabin pessary

Time frame: From insertion of Arabin pessary until birth of the foetus

Combination with progestogen therapy

Addition of progestogen therapy either vaginally or parenterally

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.